ARCHIVES

Monoclonal Antibody Improves AML Response To Therapy

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

Shortage Of Patients In Right Place, Time Develops As Major Problem For Investigators

May 3, 1974

FDA Approves Rituxan For CLL

February 19, 2010

Interview: A Conversation with Robert Carlson

October 5, 2012